Non-ignorable missing covariate data in survival analysis: a case-study of an International Breast Cancer Study Group trial

被引:24
作者
Herring, AH
Ibrahim, JG
Lipsitz, SR
机构
[1] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
Cox model; Gibbs sampling; Monte Carlo EM algorithm; non-ignorable missing covariates; quality of life;
D O I
10.1046/j.1467-9876.2003.05168.x
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Non-ignorable missing data, a serious problem in both clinical trials and observational studies, can lead to biased inferences. Quality-of-life measures have become increasingly popular in clinical trials. However, these measures are often incompletely observed, and investigators may suspect that missing quality-of-life data are likely to be non-ignorable. Although several recent references have addressed missing covariates in survival analysis, they all required the assumption that missingness is at random or that all covariates are discrete. We present a method for estimating the parameters in the Cox proportional hazards model when missing covariates may be non-ignorable and continuous or discrete. Our method is useful in reducing the bias and improving efficiency in the presence of missing data. The methodology clearly specifies assumptions about the missing data mechanism and, through sensitivity analysis, helps investigators to understand the potential effect of missing data on study results.
引用
收藏
页码:293 / 310
页数:18
相关论文
共 40 条
[1]  
Andersen P. K., 2012, Statistical models based on counting processes
[2]  
Bernhard J, 1998, STAT MED, V17, P587, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<587::AID-SIM806>3.0.CO
[3]  
2-#
[4]   A method-of-moments estimation procedure for categorical quality-of-life data with nonignorable missingness [J].
Bonetti, M ;
Cole, BF ;
Gelber, RD .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (448) :1025-1034
[5]   COVARIANCE ANALYSIS OF CENSORED SURVIVAL DATA [J].
BRESLOW, N .
BIOMETRICS, 1974, 30 (01) :89-99
[6]   Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients [J].
CastiglioneGertsch, M ;
Goldhirsch, A ;
Gusterson, B ;
Bettelheim, R ;
Reed, R ;
Gusset, H ;
Geiser, K ;
Hurny, C ;
Bernhard, J ;
Hangartner, A ;
Maibach, R ;
Pedowski, R ;
Gelber, R ;
Price, K ;
Peterson, H ;
Zelen, M ;
Isley, M ;
Hinkle, R ;
Kay, RG ;
Holdaway, IM ;
Harvey, VJ ;
Jagusch, MF ;
Neave, L ;
Mason, BM ;
Evans, B ;
Benjamin, CS ;
Carter, JF ;
Gillman, JC ;
Mack, D ;
BensonCooper, D ;
Monfardini, S ;
Galligioni, E ;
Crivellari, D ;
Buonadonna, A ;
Massarut, S ;
Rossi, C ;
Candiani, E ;
Carbone, A ;
Volpe, R ;
Trovo, MG ;
Roncadin, M ;
Santini, GF ;
Villalta, D ;
Coran, F ;
Morassut, S ;
Marini, G ;
Simoncini, E ;
Marpicati, P ;
Zaniboni, A ;
Sartori, U .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1385-1394
[7]   Proportional hazards regression with missing covariates [J].
Chen, HY ;
Little, RJA .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (447) :896-908
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]  
Fairclough DL, 1998, STAT MED, V17, P781, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<781::AID-SIM821>3.3.CO
[10]  
2-F